22 Sep 2025 | 5 Mins Read
Glenmark board to consider interim dividend
Flipitmoney
Glenmark Pharmaceuticals Ltd informed its board will meet on September 26, 2025, to consider an interim dividend for FY26. Record date for payment is set as September 30, 2025, following a net profit decline of 86.2% at ₹46.8 crore in Q1FY26. Revenue increased to ₹3,264 crore, with a 3.7% growth in India formulation business. Shares closed at ₹2,014.35, down 3.37%.